PHP
SWAV

Parkman Healthcare Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Parkman Healthcare Partners’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,076
Closed -$2.88M – 114
2023
Q2 		$2.88M Sell
10,076
-36,779
-78% -$10.2M 0.5% 60
2023
Q1 		$10.2M Buy
+46,855
New +$9.13M 2.21% 10

Other funds holding SWAV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Parkman Healthcare Partners's SWAV Position: Q3 2023 in Review

Parkman Healthcare Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 10,076 shares — an estimated $2.88M sold.

Parkman Healthcare Partners first reported a position in SWAV in Q1 2023 and held it in 2 quarters. The position peaked at $10.2M in Q1 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Parkman Healthcare Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 10,076 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $2.88M.
  • Parkman Healthcare Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Parkman Healthcare Partners's Shockwave Medical, Inc. Common Stock position peaked at $10.2M in Q1 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.